MARLTON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced two major ...

The partnership simplifies reconciliation, reporting, and managing refunds across multiple processors. Restaurant operators can now access valuable insights into guest purchasing history, shaping ...

Hitachi Energy, a global leader in electrification, today announces a new deal worth up to $700 million USD with E.ON to deliver transformers across the German energy grid to bolster energy security, ...

Re-Vana Therapeutics Ltd, founded in 2016 as a spin-out from Queen’s University Belfast, is an ocular therapeutics and innovative ocular drug delivery company based in Belfast, Northern Ireland, and a ...

Fort Worth, TX – July 28, 2025 — Audiense, the leading audience intelligence platform, today unveiled its MCP (Model Context Protocol) connectors – seamless integrations that bring audience insights ...

Xi put forward three proposals for the future of China-EU relations: both sides should uphold mutual respect and consolidate the positioning of their relations as partnership, embrace openness and ...

SecureGPU™ aligns with VCI Global’s broader platform strategy by integrating natively with V-Gallant’s Vault orchestration platform and the QuantGold encrypted data exchange. This positions VCI Global ...

COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year ...

The randomized, double-blind, placebo-controlled SAFE KIDNEY II trial enrolled 95 patients across 22 U.S. sites ( NCT05769582 ) to evaluate the clinical effectiveness of potravitug in reducing BKPyV ...

The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025.

The CHMP’s recommendation for ZURZUVAE will now be reviewed by the EC for marketing authorization in the European Union with a final decision expected in the third quarter of 2025. The U.S. FDA ...

In a milestone for California’s evolving insurance landscape, the California Department of Insurance (CDI) has completed its review of the Verisk Wildfire Model for the United States for use by ...